Trial intelligence / Profile preview

Voluven vs HSA in Pediatric Open-Heart Surgery

NCT00860405Phase 4Completed

Sponsor
Fresenius Kabi
Start
Mar 2009
Primary completion
Aug 2010
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
2
01

Overview

A Phase 4 trial of Volulyte in hypovolemia, sponsored by Fresenius Kabi. Started Mar 2009; status: completed.

02

Drugs

Volulyte
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT00860405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00860405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call